Related references
Note: Only part of the references are listed.Influenza A virus interactions with macrophages: Lessons from epithelial cells
Tina Meischel et al.
CELLULAR MICROBIOLOGY (2020)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Influenza A Virus Hemagglutinin-Neuraminidase-Receptor Balance: Preserving Virus Motility
Erik de Vries et al.
TRENDS IN MICROBIOLOGY (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal
Elana Ben-Akiva et al.
SCIENCE ADVANCES (2020)
Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry
Daniel Lauster et al.
NATURE NANOTECHNOLOGY (2020)
Quantification of Multivalent Interactions between Sialic Acid and Influenza A Virus Spike Proteins by Single-Molecule Force Spectroscopy
Jose Luis Cuellar-Camacho et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
Qiangzhe Zhang et al.
NANO LETTERS (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Influenza as a molecular walker
P. H. (Erik) Hamming et al.
CHEMICAL SCIENCE (2020)
Mobility-Based Quantification of Multivalent Virus-Receptor Interactions: New Insights Into Influenza A Virus Binding Mode
Matthias Mueller et al.
NANO LETTERS (2019)
A small-molecule fusion inhibitor of influenza virus is orally active in mice
Maria J. P. van Dongen et al.
SCIENCE (2019)
Influenza Neuraminidase: Underrated Role in Receptor Binding
Feng Wen et al.
TRENDS IN MICROBIOLOGY (2019)
Influenza A virus surface proteins are organized to help penetrate host mucus
Michael D. Vahey et al.
ELIFE (2019)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
Synthesis of Highly Efficient Multivalent Disaccharide/[60]Fullerene Nanoballs for Emergent Viruses
Javier Ramos-Soriano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Competition for Membrane Receptors: Norovirus Detachment via Lectin Attachment
Nagma Parveen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Broadly protective human antibodies that target the active site of influenza virus neuraminidase
Daniel Stadlbauer et al.
SCIENCE (2019)
Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
Xiao Han et al.
SCIENCE ADVANCES (2019)
Lectin microarray analyses reveal host cell-specific glycan profiles of the hemagglutinins of influenza A viruses
Takahiro Hiono et al.
VIROLOGY (2019)
Cell Membrane Coating Nanotechnology
Ronnie H. Fang et al.
ADVANCED MATERIALS (2018)
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
Yao-Qing Chen et al.
CELL (2018)
Nanocarbon-Based Glycoconjugates as Multivalent Inhibitors of Ebola Virus Infection
Laura Rodriguez-Perez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
Nick S. Laursen et al.
SCIENCE (2018)
Nanostructured glycan architecture is important in the inhibition of influenza A virus infection
Seok-Joon Kwon et al.
NATURE NANOTECHNOLOGY (2017)
Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014
R. Trebbien et al.
EUROSURVEILLANCE (2017)
Multivalent Glycosylated Nanostructures To Inhibit Ebola Virus Infection
Beatriz M. Illescas et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo
Sumati Bhatia et al.
BIOMATERIALS (2017)
Multivalent Peptide-Nanoparticle Conjugates for Influenza-Virus Inhibition
Daniel Lauster et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection
Antonio Munoz et al.
NATURE CHEMISTRY (2016)
Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
Huiping Sun et al.
ADVANCED MATERIALS (2016)
Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors
Brian T. Luk et al.
THERANOSTICS (2016)
Image Restoration and Analysis of Influenza Virions Binding to Membrane Receptors Reveal Adhesion-Strengthening Kinetics
Donald W. Lee et al.
PLOS ONE (2016)
Preserved Transmembrane Protein Mobility in Polymer-Supported Lipid Bilayers Derived from Cell Membranes
Hudson Pace et al.
ANALYTICAL CHEMISTRY (2015)
Self-Organized Mesostructured Hollow Carbon Nanoparticles via a Surfactant-Free Sequential Heterogeneous Nucleation Pathway
Hongwei Zhang et al.
CHEMISTRY OF MATERIALS (2015)
Size Dependence of Steric Shielding and Multivalency Effects for Globular Binding Inhibitors
Jonathan Vonnemann et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
A Nanomolar Multivalent Ligand as Entry Inhibitor of the Hemagglutinin of Avian Influenza
Moritz Waldmann et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Nanoparticle-detained toxins for safe and effective vaccination
Che-Ming J. Hu et al.
NATURE NANOTECHNOLOGY (2013)
A biomimetic nanosponge that absorbs pore-forming toxins
Che-Ming J. Hu et al.
NATURE NANOTECHNOLOGY (2013)
Interaction of Single Viruslike Particles with Vesicles Containing Glycosphingolipids
M. Bally et al.
PHYSICAL REVIEW LETTERS (2011)
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
Jesse D. Bloom et al.
SCIENCE (2010)
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2009)
The pathology of influenza virus infections
Jeffery K. Taubenberger et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Influenza vaccine: The challenge of antigenic drift
F. Carrat et al.
VACCINE (2007)
Solid supported lipid bilayers: From biophysical studies to sensor design
Edward T. Castellana et al.
SURFACE SCIENCE REPORTS (2006)
Influenza-associated hospitalizations in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Visualizing infection of individual influenza viruses
M Lakadamyali et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Functional balance between haemagglutinin and neuraminidase in influenza virus infections
R Wagner et al.
REVIEWS IN MEDICAL VIROLOGY (2002)
Share Paper
